Healthcare Services Group, Inc. (HCSG) Stock Price & Analysis
Healthcare Services Group, Inc. (HCSG) closed at USD 21.43 on Thursday, October 15, 2026, up 1.95% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 21.02; the Oct 15, 2026 session ranged USD 21.18–21.67 on volume of 521,722 shares. Market capitalization is $1.47B, with a 52-week range of USD 16.09–25.75 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:20 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HCSG.md
Key facts (HCSG)
- Last four reported quarters (through Jun 30, 2026): revenue $1.86B, net income $123M (6.6% margin), free cash flow $149M (SEC filings).
- Valuation: P/E 12.0x (avg 21.8x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold HCSG (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 2.43 on a 1–5 scale) (7 analysts), mean target USD 26.67 (range 24–30).
- Total return with dividends: 1Y +30.5% vs S&P 500 +18.1%; 5Y +0.9% vs S&P 500 +85.1%.
- Next earnings: 2026-10-21, EPS estimate USD 0.24, revenue estimate $481M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HCSG)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.64B | $1.69B | $1.67B | $1.72B | $1.84B | $1.86B |
| Gross profit | $231M | $193M | $215M | $228M | $239M | — |
| Net income | $48.5M | $34.2M | $38.4M | $39.5M | $59.1M | $123M |
| EPS (diluted) | $0.65 | $0.46 | $0.52 | $0.53 | $0.81 | — |
| Free cash flow | $31.4M | -$13.4M | $38.1M | $24.5M | $139M | $149M |
| Gross margin | 14.0% | 11.4% | 12.8% | 13.3% | 13.0% | — |
| Net margin | 3.0% | 2.0% | 2.3% | 2.3% | 3.2% | 6.6% |
| Revenue growth | -6.7% | +2.9% | -1.1% | +2.7% | +7.1% | — |
| Cash + short-term investments | $185M | $121M | $147M | $107M | $168M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (HCSG)
P/E 12.0x · P/S 0.8x · P/FCF 9.9x · P/B 2.8x · FCF yield 10.10% · Earnings yield 8.36% · Buyback yield (TTM) 6.24%
P/E at fiscal year-ends: Dec 2025 23.6x, Dec 2024 21.8x, Dec 2023 20.1x.
Superinvestors (SEC 13F-HR, Q2 2026) (HCSG)
1 of 80 tracked investors hold HCSG. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.02% | $13.5M | Added +15.5% |
Analysts (HCSG)
Consensus Buy (mean 2.43 on a 1–5 scale), 7 analysts; mean target USD 26.67 (low 24, high 30).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-08 | Baird | Target lowered | Neutral | $26 → $24 |
| 2026-08-19 | Oppenheimer | Initiated | Outperform | $28 |
| 2026-07-08 | UBS | Target raised | Buy | $27 → $30 |
Total return (dividends reinvested) (HCSG)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +30.5% | +0.9% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +30.6% | +0.2% |
| Volatility (annualized) | 40.4% | 41.4% |
| Max drawdown | -19.9% (Feb 2026→Apr 2026) | -56.2% (Oct 2021→Jan 2024) |
Key Statistics (as of October 16, 2026 at 05:20 UTC)
| Price | USD 21.43 |
|---|---|
| Change | ▲ 1.95% (up) |
| Previous Close | USD 21.02 |
| Open | USD 21.34 |
| Day Range | USD 21.18 – 21.67 |
| 52-Week Range | USD 16.09 – 25.75 |
| Volume | 521,722 shares |
| Market Cap | $1.47B |
| Exchange | NMS |
Technical Analysis (HCSG)
Nexqual's technical model rates HCSG "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of October 16, 2026 at 05:20 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 52.87 (neutral) |
| vs SMA50 | Below (USD 21.61) |
| MACD | -0.22 (negative) |
Analyst Ratings (HCSG)
Wall Street analysts rate HCSG "Buy" based on 7 analysts, with a mean price target of USD 26.67 (range USD 24–30), per Nexqual as of October 16, 2026 at 05:20 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 7 |
| Mean Target | USD 26.67 |
| High Target | USD 30 |
| Low Target | USD 24 |
| Buy / Hold / Sell | 4 / 3 / 0 |
Earnings (HCSG)
| Next Earnings Date | 2026-10-21 |
|---|---|
| EPS Estimate | USD 0.24 |
| Revenue Estimate | $480.79M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.32 vs est 0.22 ▲ beat |
| 2026-03-31 | USD 0.37 vs est 0.22 ▲ beat |
| 2025-12-31 | USD 0.44 vs est 0.22 ▲ beat |
| 2025-09-30 | USD 0.59 vs est 0.2 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Financials & Fundamentals (HCSG)
| Total Revenue | $1.86B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +2.70% |
| Gross Margin | +17.11% |
| Operating Margin | +4.72% |
| Profit Margin | +6.59% |
| ROE | +24.69% |
| Debt / Equity | 0.03 |
| Current Ratio | 3.02 |
| Total Cash | $164.72M |
| Total Debt | $17.73M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $139.15M (7.6% of revenue) |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Financial Health Score (HCSG)
Nexqual rates Healthcare Services Group, Inc.'s overall financial health "Solid" across five dimensions, as of October 16, 2026 at 05:20 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 17%, operating 5% |
| Balance Sheet | Strong — $165M cash vs $18M debt, net cash position |
| Cash Flow | Solid — FCF $139M (FY ended Dec 2025, 10-K), 8% margin |
| Efficiency | Strong — ROE 25%, ROA 9.8% |
Ownership (HCSG)
| Insider Ownership | +1.39% |
|---|---|
| Institutional Ownership | +112.96% |
| Shares Outstanding | 68.63M |
| Float | 67.85M |
| Short % of Float | +4.74% |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Leadership (HCSG)
Healthcare Services Group, Inc. is led by Theodore Wahl (age 51), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:20 UTC.
| President, CEO & Director | Theodore Wahl (age 51) |
|---|---|
| Executive VP & CFO | Vikas Singh (age 48) |
| Executive VP & COO | Andrew W. Kush AAI (age 47) |
| Executive VP & Chief Revenue Officer | Patrick J. Orr (age 50) |
Major Backers & Investors (HCSG)
Notable institutional backers of Healthcare Services Group, Inc. include American Century Companies Inc, FMR, LLC, Ameriprise Financial, Inc., according to Nexqual as of October 16, 2026 at 05:20 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century Companies Inc | 6.95% |
| FMR, LLC | 3.35% |
| Ameriprise Financial, Inc. | 3.29% |
| Royce & Associates LP | 3.26% |
| Fidelity | 2.7% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 25.27% |
| Vanguard Group | 19.9% |
| State Street | 4.25% |
| Geode Capital | 3.73% |
| Dimensional Fund Advisors | 3.62% |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMN | AMN Healthcare Services Inc | USD 40 | ▲ 9.47% |
| PNTG | The Pennant Group, Inc. | USD 42.27 | ▲ 5.28% |
| AGL | agilon health, inc. | USD 88.45 | ▲ 2.97% |
| NUTX | Nutex Health Inc. | USD 200.8 | ▼ 1.74% |
| CMPS | COMPASS Pathways Plc - American | USD 11.62 | ▲ 4.31% |
| USPH | U.S. Physical Therapy, Inc. | USD 85.98 | ▲ 0.63% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:20 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt